Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee advances bill barring prior authorization for certain antipsychotics after fiscal debate
Summary
House Bill 610, which would prohibit prior authorization for certain emergency uses of schizophrenia and bipolar medications in Medicaid, passed the committee. The Department of Public Health and Human Services disputed the fiscal estimate and said loss of supplemental rebates and shifts in utilization drive costs in the fiscal note.
House Bill 610, a bill to restrict prior authorization requirements for antipsychotic medications used for schizophrenia and bipolar disorder in Medicaid, moved out of the House Appropriations Committee following extended testimony and a 20-3 recorded vote in favor.
The sponsor described the bill as narrowly targeted emergency use language and urged collaboration with the department on fiscal estimates. Industry representative Chris Averill, testifying for Alkermes, said the fiscal note understates the number of claims that the current…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
